a London School of Hygiene and Tropical Medicine , Department of Global Health and Development , Tavistock Place, London , UK.
b Bill and Melinda Gates Foundation , Seattle , WA , USA.
Hum Vaccin Immunother. 2018 Jun 3;14(6):1539-1541. doi: 10.1080/21645515.2018.1444321. Epub 2018 Mar 26.
National Immunisation Technical Advisory Groups (NITAGs) provide independent guidance to health ministries to support evidence-based and nationally relevant immunisation decisions. We examined NITAGs' value, sustainability, and need for support in low and middle-income countries, drawing from a mixed-methods study including 130 global and national-level key informant interviews. NITAGs were particularly valued for providing independent and nationally owned evidence-based decision-making (EBDM), but needed to be integrated within national processes to effectively balance independence and influence. Participants agreed that most NITAGs, being relatively new, would need developmental and strengthening support for at least a decade. While national governments could support NITAG functioning, external support is likely needed for requisite capacity building. This might come from Gavi mechanisms and WHO, but would require alignment among stakeholders to be effective.
国家免疫技术咨询小组(NITAGs)为卫生部提供独立指导,以支持基于证据和具有国家相关性的免疫决策。我们从一项包括 130 次全球和国家级关键意见访谈的混合方法研究中,研究了 NITAGs 在低收入和中等收入国家的价值、可持续性以及对支持的需求。NITAGs 特别受到重视,因为它们提供了独立和国家拥有的基于证据的决策制定(EBDM),但需要整合到国家流程中,以有效地平衡独立性和影响力。参与者一致认为,大多数 NITAGs 相对较新,至少需要十年的发展和加强支持。虽然国家政府可以支持 NITAG 的运作,但可能需要外部支持来进行必要的能力建设。这可能来自 Gavi 机制和世卫组织,但需要利益相关者之间的协调才能有效。